World's Best Scientists 2026 revealed!
Claudio Lunardi

Claudio Lunardi

D-Index & Metrics

Immunology

D-Index
50
Citations
9895
World Ranking
4233
National Ranking
177

Claudio Lunardi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Claudio Lunardi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 247 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Claudio Lunardi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Claudio Lunardi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Claudio Lunardi is affiliated with the University of Verona in Italy. Their research primarily spans the field of Medicine, with a specific focus on Rheumatology, Pulmonary and Respiratory Medicine, Immunology, Surgery, and Physiology. Lunardi's work addresses a range of significant topics within these fields, including Eosinophilic Disorders and Syndromes, Vasculitis and related conditions, Asthma and respiratory diseases, Immunodeficiency and Autoimmune Disorders, Urticaria and Related Conditions, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, and Eosinophilic Esophagitis.

Recent publications by Lunardi include:

  • "Baricitinib restrains the immune dysregulation in patients with severe COVID-19" (2020) in Journal of Clinical Investigation
  • "Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study" (2021) in Arthritis & Rheumatology
  • "Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality" (2020) in Journal of Allergy and Clinical Immunology
  • "A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19" (2020) in Thrombosis Research
  • "Gene Expression Profiling in Fibromyalgia Indicates an Autoimmune Origin of the Disease and Opens New Avenues for Targeted Therapy" (2020) in Journal of Clinical Medicine

Lunardi frequently collaborates with several co-authors who have contributed repeatedly to their research projects. These co-authors include Elisa Tinazzi, Angelo Vacca, Marco Caminati, Gianenrico Senna, and Simonetta Friso.

The scientist regularly publishes in specific academic venues, reflecting their area of expertise. These frequent publication venues include:

  • Arthritis & Rheumatology
  • The Journal of Allergy and Clinical Immunology In Practice
  • Biomedicines
  • Journal of Clinical Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)

Lunardi's research contributions cover a considerable scope within their main and subfields, focusing on diseases and conditions related to immune function and respiratory health. Their work extends to understanding autoimmune origins and potential targeted therapies for complex conditions such as fibromyalgia and eosinophilic disorders.

Best Publications

  • Evidence for a cross-talk between human neutrophils and Th17 cells

    Martin Pelletier;Laura Maggi;Alessandra Micheletti;Elena Lazzeri

  • Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

    L. Van Bon;L. Van Bon;A. J. Affandi;A. J. Affandi;J. Broen;J. Broen;R. B. Christmann

  • Identification of a novel antibody associated with autoimmune pancreatitis

    Luca Frulloni;Claudio Lunardi;Rita Simone;Marzia Dolcino

  • Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells.

    Claudio Lunardi;Caterina Bason;Riccardo Navone;Enrico Millo

  • Mature CD10+ and immature CD10− neutrophils present in G-CSF–treated donors display opposite effects on T cells

    Olivia Marini;Sara Costa;Dalila Bevilacqua;Federica Calzetti

  • Baricitinib restrains the immune dysregulation in patients with severe COVID-19.

    Vincenzo Bronte;Stefano Ugel;Elisa Tinazzi;Antonio Vella

  • In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes.

    Giovanna Zanoni;Riccardo Navone;Claudio Lunardi;Giuseppe Tridente

  • Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome.

    Claudio Lunardi;Caterina Bason;Massimo Leandri;Riccardo Navone

  • Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy

    Olga Gorlova;Jose Ezequiel Martin;Blanca Rueda;Bobby P C Koeleman

  • Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis

    Maureen D. Mayes;Lara Bossini-Castillo;Olga Gorlova;José Ezequiel Martin

  • Human parvovirus B19 infection and autoimmunity.

    Claudio Lunardi;Elisa Tinazzi;Caterina Bason;Marzia Dolcino

  • A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

    F. David Carmona;Sarah L. Mackie;Jose Ezequiel Martín;John C. Taylor

  • International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management

    Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Chiara Baldini

  • Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties

    Claudio Lunardi;Micaela Tiso;Lorena Borgato;Luca Nanni

  • Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study

    Alessandra Bettiol;Maria Letizia Urban;Lorenzo Dagna;Vincent Cottin

  • Antibodies against Human Cytomegalovirus in the Pathogenesis of Systemic Sclerosis: A Gene Array Approach

    Claudio Lunardi;Marzia Dolcino;Dimitri Peterlana;Caterina Bason

  • Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-α?

    M. Cigolini;M. Tonoli;L. Borgato;L. Frigotto

  • Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis.

    Caterina Bason;Roberto Corrocher;Claudio Lunardi;Patrizia Puccetti

  • DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis.

    Mara Oliveri;Antonio Daga;Claudia Cantoni;Claudio Lunardi

  • In chronic idiopathic urticaria autoantibodies against FcεRII/CD23 induce histamine release via eosinophil activation

    A. Puccetti;Caterina Bason;Sara Simeoni;E. Millo

  • A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci

    Jose Ezequiel Martin;Shervin Assassi;Lina Marcela Diaz-Gallo;Jasper C. Broen;Jasper C. Broen

Frequent Co-Authors

Torsten Witte
Torsten Witte Hannover Medical School
Jane Worthington
Jane Worthington University of Manchester
Timothy R D J Radstake
Timothy R D J Radstake Utrecht University
Christopher P. Denton
Christopher P. Denton University College London
Ariane L. Herrick
Ariane L. Herrick University of Manchester
Paolo Airò
Paolo Airò University of Brescia
Roberto Gerli
Roberto Gerli University of Perugia
Maureen D. Mayes
Maureen D. Mayes The University of Texas at Austin
Bobby P.C. Koeleman
Bobby P.C. Koeleman Utrecht University
Gabriela Riemekasten
Gabriela Riemekasten University of Lübeck

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing advanced degrees in nursing and healthcare can open diverse career pathways. Many professionals begin by exploring online accelerated nursing programs for non nurses, which offer a fast track into the nursing field without prior experience.

Registered Nurses looking to specialize often benefit from accelerated RN to NP programs, facilitating a smoother transition to becoming Nurse Practitioners. For those aiming to move from general practice to more specialized roles, ACNP programs (Acute Care Nurse Practitioner) focus on the skills needed to manage acute and complex conditions.

Understanding the financial landscape is also crucial. According to data on highest paid DNP specialties, salaries vary significantly by state and specialization, highlighting the importance of aligning your education with market demand.

By combining these pathways with a background in Immunology, professionals can build rewarding careers in healthcare, research, and specialized clinical roles with strong growth potential.

Best Scientists Citing Claudio Lunardi

Trending Scientists

Recently Published Articles